Dominic Schmidt
InvestorGeneral Partner at Advent Life Sciences
London
Writes $25K – $5M checks · typically $1M
About
Dominic Schmidt joined Advent Life Sciences in April 2022, with a background in biochemistry, genomics, molecular oncology, strategy consulting, and life science venture capital. He previously spent eight years as a Partner on the investment team at Syncona, a publicly listed healthcare investment company, where he helped found and grow several life science businesses. He holds a Diplom in Biochemistry from the Free University of Berlin and the Max Planck Institute for Molecular Genetics, and a PhD in Oncology from the University of Cambridge.
Invests in
BiotechLongevity
Experience
- Advent Life SciencesGeneral Partnercurrent2022 — presentLondon, England, United Kingdom
- Glycomine Inc.Non Executive Directorcurrent2024 — presentUnited States
- Beacon TherapeuticsBoard Observercurrent2024 — present
- Pheno Therapeutics LtdNon Executive Directorcurrent2024 — presentEdinburgh, Scotland, United Kingdom
- AviadoBioNon Executive Directorcurrent2022 — presentLondon, England, United Kingdom
- Amphista Therapeutics LimitedNon Executive Directorcurrent2022 — presentCambridge, England, United Kingdom
- Purespring TherapeuticsNon Executive Director2020 — 2022
- Forcefield TherapeuticsNon Executive Director2020 — 2022
- Anaveon AGNon Executive Director2019 — 2022Switzerland
- Syncona LimitedPartner2016 — 2022London, United Kingdom
- Syncona LimitedPartner2014 — 2016London, United Kingdom
- GYROSCOPE Therapeutics LtdNon Executive Director and Board Observer2019 — 2022
- Orbit Biomedical, Inc.Non Executive Director2018 — 2021London / Philadelphia
- Freeline Therapeutics LimitedBoard Observer2015 — 2020London
- L.E.K. ConsultingAssociate2012 — 2014
- Cancer Research UKDoctoral Student2007 — 2011
- Max Planck Institute for Molecular GeneticsMaster Student and Research Assistant2006 — 2007
Skills & more
Lifesciences27Genomics14Due Diligence19Biotechnology12Private Equity6Statistics5Biochemistry7Oncology2Management Consulting5Molecular Biology9Valuation5Cell Culture5
+10 more
StrategyBioinformaticsBusiness StrategyCell BiologyGeneticsData AnalysisLife SciencesStrategy ConsultingVenture CapitalFinancial ModelingLanguages English · German
From Dominic's professional profile.
Investments
Board seats
AmphistaAviadoBio WebsiteBeacon TherapeuticsGlycomineGyroscope TherapeuticsOrbit BiomedicalPheno Therapeutics
Per the firm's website.
Colleagues at Advent Life Sciences
Alain Huriez
Venture Partner at Advent Life Sciences
Alan Walts
Venture Partner at Advent Life Sciences
Andrea Beesley
Team Assistant at Advent Life Sciences
Bonita Theara
Executive Assistant at Advent Life Sciences
Don Drakeman
Distinguished Research Professor, biotech entrepreneur, and venture partner
Fraser Murray
Head of Scientific Evaluation at Advent Life Sciences
Gail Jermyn
Investor Relations Partner at Advent Life Sciences
George Cadbury
Partner at GVP Climate
Network5
Alain Huriez
Venture Partner at Advent Life Sciences
Alan Walts
Venture Partner at Advent Life Sciences
Don Drakeman
Distinguished Research Professor, biotech entrepreneur, and venture partner
Kaasim Mahmood
General Partner at Advent Life Sciences
Karen LaRochelle
Venture Partner at Advent Life Sciences
Investors connected to Dominic in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Dominic Schmidt?
- Dominic Schmidt joined Advent Life Sciences in April 2022, with a background in biochemistry, genomics, molecular oncology, strategy consulting, and life science venture capital. He previously spent eight years as a Partner on the investment team at Syncona, a publicly listed healthcare investment company, where he helped found and grow several life science businesses. He holds a Diplom in Biochemistry from the Free University of Berlin and the Max Planck Institute for Molecular Genetics, and a PhD in Oncology from the University of Cambridge.
- Where does Dominic Schmidt work?
- Dominic Schmidt is General Partner at Advent Life Sciences.
- What does Dominic Schmidt invest in?
- Dominic Schmidt invests in Biotech, Longevity.
- What check size does Dominic Schmidt write?
- Dominic Schmidt typically writes checks of $25K – $5M.
- What boards does Dominic Schmidt sit on?
- Dominic Schmidt holds tracked board seats at Amphista, AviadoBio Website, Beacon Therapeutics, Glycomine, Gyroscope Therapeutics, Orbit Biomedical, Pheno Therapeutics.
- Where did Dominic Schmidt go to school?
- Dominic Schmidt studied at University of Cambridge (Doctor of Philosophy (Ph.D.), Oncology); Freie Universität Berlin (German Diplom Degree / M.Sc., Biochemistry).
Same school
Also attended University of Cambridge893
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
.png)
+ 887 more
Also attended Freie Universität Berlin70
Mina BenothmanOther at HeavybitJeannette zu FürstenbergPresident & Managing Director at General CatalystHilla WatkinsPlatform Partner at Congruent VenturesDavid FrazeeManaging Partner at Richmond Global VenturesLucas LaibPartner, COO at Verve VenturesChris ShanahanPrincipal at DFJ
+ 64 more
Shared employers
Also worked at Amphista Therapeutics Limited4
Also worked at Anaveon AG3
Also worked at Syncona Limited5
Also worked at Cancer Research UK24
Drew BurdonInvestor at LSP (Life Sciences Partners)Giovanni MariggiInvestor at MedicxiJoanna SorokaInvestment Partner at Hitachi VenturesMilenko CicmilVenture Partner at Cure VenturesMartin TaylorPrincipal at F-Prime Capital PartnersAlex Badamchi-ZadehVice President at SV Health Investors
+ 18 more